GSK plc

GSK plc EBITDA per Employee

The EBITDA per Employee of GSK plc (GSK.L) as of Oct 19, 2026 is 83,856.02 GBP. In the previous year, EBITDA per Employee was 60,776.48 GBP — a change of 37.97% (higher).

EBITDA per Employee

83,856.02GBP

YoY

37.97%

Last updated:

EBITDA per Employee of GSK plc is 2025 83,856.02 GBP. EBITDA per Employee of GSK plc was 2024 60,776.48 GBP. It decreases by 37.97% higher compared to the previous year.

The GSK plc EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
85,503.80 GBP
Jan 1, 2019
83,420.15 GBP
Jan 1, 2020
87,789.42 GBP
Jan 1, 2021
58,533.37 GBP
Jan 1, 2022
72,002.64 GBP
Jan 1, 2023
75,106.84 GBP
Jan 1, 2024
60,776.48 GBP
Jan 1, 2025
83,856.02 GBP
The GSK plc EBITDA per Employee history
YEAREBITDA per EmployeeYoY
83,856.02GBP+37.97%
60,776.48GBP-19.08%
75,106.84GBP+4.31%
72,002.64GBP+23.01%
58,533.37GBP-33.33%
87,789.42GBP+5.24%
83,420.15GBP-2.44%
85,503.80GBP+0.30%
85,248.66GBP+16.71%
73,044.46GBP+52.62%
47,860.01GBP-9.43%
52,845.87GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GSK plc Stock analysis

What does GSK plc do? GSK plc, listed on the London Stock Exchange under the ticker GSK.L, is a pharmaceutical company headquartered in Brentford, United Kingdom. The company, which has been publicly traded since May 22, 1972, operates within the healthcare sector, specifically in the pharmaceuticals industry. GSK employs 94,066 full-time staff, focusing on the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. The company's operations are structured around two primary segments: Pharmaceuticals and Vaccines. In the Pharmaceuticals segment, GSK develops and markets medicines for a variety of conditions, including respiratory diseases, HIV and infectious diseases, immuno-inflammation, oncology, and rare diseases. The Vaccines segment provides immunization solutions for all age groups, from infants to the elderly, including pediatric, adolescent, adult, and travel vaccines. GSK's portfolio includes prescription medicines and vaccines, with a particular emphasis on respiratory and HIV-related treatments. The company's business strategy encompasses both innovative therapeutic areas and established product lines, supporting its global presence in healthcare. GSK's official website is www.gsk.com, offering further information about its products and initiatives. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

EBITDA per Employee of GSK plc is 83,856.02 GBP in 2025.

EBITDA per Employee of GSK plc changed from 60,776.48 GBP to 83,856.02 GBP, representing a 37.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee GSK plc since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's GSK plc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — GSK plc

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — GSK plc